Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

MRNS Marinus Pharmaceuticals Inc

0,54

0,003 (0,56%)

14 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Marinus Pharmaceuticals Charts.

Marinus Pharmaceuticals (NASDAQ:MRNS)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Marinus Pharmaceuticals Charts.

News Marinus Pharmaceuticals Inc

Form SC TO-T - Tender offer statement by Third Party
Mittwoch 8 Januar 2025 (5 Tage vor) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Mittwoch 8 Januar 2025 (6 Tage vor) • Edgar (US Regulatory)

Form SC TO-C - Written communication relating to an issuer or third party
Donnerstag 2 Januar 2025 (2 Wochen vor) • Edgar (US Regulatory)

Form SC14D9C - Written communication relating to third party tender offer
Montag 30 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 30 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 30 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Immedica to Acquire Biopharmaceutical Company Marinus Pharmaceuticals, Inc.
Montag 30 Dezember 2024 (2 Wochen vor) • Business Wire

Form 8-K - Current report
Montag 23 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 10 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Dienstag 10 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Marinus Pharmaceuticals Inc News-Artikel

Societe Generale Effekten

L&G Artificial Intellige...

Net Insurance AOR

Societe Generale Effekten

MSCI USA Small Cap ESG L...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen